Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 2, 2008, Pages 222-227

  Marcos, Luis A ^a   Tagle, Martin ^a,b   Terashima, Angelica ^a   Bussalleu, Alejandro ^a,b   Ramirez, Cesar ^b   Carrasco, Carlos ^b   Valdez, Luis ^a   Huerta Mercado, Jorge ^b   Freedman, David O ^c   Vinetz, Joseph M ^d   Gotuzzo, Eduardo ^a  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CONTRAST MEDIUM; TRICLABENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; HELMINTH ANTIBODY; PARASITE ANTIGEN;

ABDOMINAL PAIN; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CALCIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FASCIOLA HEPATICA; FASCIOLIASIS; FECES ANALYSIS; FEMALE; FEVER; HEMATOMA; HEPATOMEGALY; HUMAN; LIVER INJURY; MALE; SINGLE DRUG DOSE; WESTERN BLOTTING; ACUTE DISEASE; ANIMAL; BLOOD; CASE REPORT; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; METHODOLOGY; MIDDLE AGED; PARASITOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; TIME; TREATMENT OUTCOME;

FASCIOLA HEPATICA; LACTUCA; MEDICAGO SATIVA; NASTURTIUM OFFICINALE;

ACUTE DISEASE; ADULT; AGED; ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BENZIMIDAZOLES; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 41249102316     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.222     Document Type: Article

References (28)

1. Esteban JG, Bargues MD, Mas-Coma S, 1998. Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Res Rev Parasitol 58: 13-42.
2. Mas-Coma S, Bargues MD, Esteban JG, 1999. Human fasciolosis. Dalton JP, ed. Fasciolosis. New York: CAB International Publishing, 411-434.
3. Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79: 207-216.
4. Mas-Coma MS, Esteban JG, Bargues MD, 1999. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77: 340-346.
5. Marcos L, Maco V, Florencio L, Terashima A, Samalvides F, Espinoza JR, Miranda E, Tantaleán M, Gotuzzo E, 2005. Altas tasas de prevalencia de fasciolosis humana en el Peru: una enfermedad emergente. Rev Peru Enf Infec Trop 3: 8-13.
6. Esteban JG, Gonzalez C, Bargues MD, Angles R, Sánchez C, Náquira C, Mas-Coma S, 2002. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 7: 339-348.
7. Knobloch J, Delgado E, Alvarez A, Reymann U, Bialek R, 1985. Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol 36: 88-90.
8. Marcos L, Maco V, Terashima A, Samalvides F, Espinoza JR, Gotuzzo E, 2004. Hiperendemicidad de fasciolosis humana en el Valle del Mantaro: factores de riesgo de la infección por Fasciola hepatica. Rev Gastroenterol Peru 24: 158-164.
9. Blancas G, Terashima A, Maguina C, Vera L, Alvarez H, Tello R, 2004. Fasciolosis humana y compromiso gastrointestinal: estudio de 277 pacientes en el Hospital Nacional Cayetano Heredia, 1970-2002. Rev Gastroenterol Peru 24: 143-157.
10. Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, Gabor M, Apt P, 1995. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 52: 532-535.
11. Maco V, Marcos L, Terashima A, Samalvides F, Miranda E, Espinoza JR, Gotuzzo E, 2002. Fas2-ELISA y la técnica de sedimentación rápida modificada por lumbreras en el diagnóstico de la infección por Fasciola hepatica. Rev Med Hered 13: 49-57.
12. Espinoza JR, Timoteo O, Herrera-Velit P, 2005. Fas2-ELISA in the detection of human infection by Fasciola hepatica. J Helminthol 79: 235-240.
13. Kabaalioglu A, Cubuk M, Senol U, Cevikol C, Karaali K, Apaydin A, Sindel T, Lüleci E, 2000. Fascioliasis: US, CT, and MRI findings with new observations. Abdom Imaging 25: 400-404.
14. Lumbreras H, Cantella R, Burga R, 1962. Acerca de un procedimiento de sedimentación rápida para investigar huevos de Fasciola hepatica en las heces, su evaluación y uso en el campo. Rev Med Peru 31: 167-174.
15. Hidalgo F, Valls C, Narvaez JA, Serra J, 1995. Hepatic fascioliasis: CT findings. AJR Am J Roentgenol 164: 768.
16. MacLean JD, Graeme-Cook FM, 2002. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2002. A 50-year-old man with eosinophilia and fluctuating hepatic lesions. N Engl J Med 346: 1232-1239.
17. Han JK, Jang HJ, Choi BI, Kim SH, Kim TK, Won HJ, Kim YI, Cho SY, 1999. Experimental hepatobiliary fascioliasis in rabbits: a radiology-pathology correlation. Invest Radiol 34: 99-108.
18. Gonzalo-Orden M, Millan L, Alvarez M, Sánchez-Campos S, Jiménez R, González-Gallego J, Tuñón MJ, 2003. Diagnostic imaging in sheep hepatic fascioliasis: ultrasound, computer tomography and magnetic resonance findings. Parasitol Res 90: 359-364.
19. Teichmann D, Grobusch MP, Gobels K, Muller HP, Koehler W, Suttorp N, 2000. Acute fascioliasis with multiple liver abscesses. Scand J Infect Dis 32: 558-560.
20. Karabinis A, Herson S, Brucker G, Nozais JP, De Puyfontaine O, Tselentis J, Godeau P, Gentilini M, 1985. Fasciola hepatic abscesses: value of hepatic ultrasonography. Apropos of 3 cases. Ann Med Interne (Paris) 136: 575-578.
21. Kim JB, Kim DJ, Huh S, Cho SY, 1995. A human case of invasive fascioliasis associated with liver abscess. Korean J Parasitol 33: 395-398.
22. Kim KA, Lim HK, Kim SH, Lee WJ, Lim JH, 1999. Necrotic granuloma of the liver by human fascioliasis: imaging findings. Abdom Imaging 24: 462-464.
23. Noyer CM, Coyle CM, Werner C, Dupouy-Camet J, Tanowitz HB, Wiitner M, 2002. Hypereosinophilia and liver mass in an immigrant. Am J Trop Med Hyg 66: 774-776.
24. Loja D, Alvizuri J, Vilca M, Aviles R, Sanchez M, 2003. Hepatic subcapsular hematoma caused by fascioliasis. Rev Gastroenterol Peru 23: 142-148.
25. MacLean JD, Cross J, Mahanty S, 1999. Liver, lung, and intestinal fluke infections. Guerrant RL, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens, & Practice. Philadelphia: Churchill Livingstone, 1039-1057.
26. Marcos L, Maco V, Samalvides F, Terashima A, Espinoza JR, Gotuzzo E, 2006. Risk factors for Fasciola hepatica infection in children: a case-control study. Trans R Soc Trop Med Hyg 100: 158-166.
27. Cosme A, Ojeda E, Cilla G, Torrado J, Alzate L, Beristain X, Orive V, Arenas J, 2001. Fasciola hepatica. Study of a series of 37 patients. Gastroenterol Hepatol 24: 375-380 (article in Spanish).
28. Keiser J, Engels D, Buscher G, Utzinger J, 2005. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 14: 1513-1526.